Dual targeted therapy with pyrotinib and trastuzumab for<scp>HER2</scp>‐positive advanced colorectal cancer: A phase 2 trialXianhua Fu, Ying Yuan, Weidong Han et al.|Cancer Science|2022Cited by 29
Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial.Ying Yuan, Suzhan Zhang, Xianhua Fu et al.|Journal of Clinical Oncology|2021Cited by 10